A colorimetric minisequencing assay for the mutation in codon 506 of the coagulation factor V gene

Thrombosis and Haemostasis

Volumn 77, Issue 4, 1997, Pages 701-703

  Sitbon, Gisela ^a   Hurtig, Maria ^a   Palotie, Aarno ^b   Lönngren, Jörgen ^a   Syvänen, Ann Christine ^c  

^a ProGene Lab AB   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBODY CONJUGATE; BLOOD CLOTTING FACTOR 5; DNA; DNA POLYMERASE; HAPTEN; PRIMER DNA;

ARTICLE; CODON; COLORIMETRY; CONTROLLED STUDY; DNA TEMPLATE; ENZYME IMMUNOASSAY; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; RESTRICTION SITE;

EID: 0030932658     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656037     Document Type: Article

References (14)

1. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
2. Zöller B, Svensson PJ, Xuhua-He, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-4.
3. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 300: 517-22.
4. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 11334.
5. März W, Seydewitz H, Winkelmann B, Chen M, Nauck M, Witt I. Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary heart disease. Lancet 1995; 345: 526-7.
6. Simioni P, de Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A. Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke 1995; 26: 885-90.
7. 506 to Gln mutation in Factor V as a pathogenic risk factor for venous thrombosis. Thromb Haemost 1995; 74: 139-48.
8. Syvänen A-C, Aalto-Setälä K, Harju L, Kontula K, Söderlund H. A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics 1990; 8: 684-92.
9. Syvänen A-C, Sajantila A, Lukka M. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am J Hum Genet 1993; 52: 46-59.
10. Ihalainen J, Siitari H, Laine S, Syvänen A-C, Palotie A. Towards automatic detection of point mutations: Use of scintillating microplates in solid-phase minisequencing. BioTechniques 1994; 16: 938-43.
11. Hietala M, Aula P, Syvänen A-C, Isoniemi A, Peltonen L, Palotie A. DNA-based carrier screening in primary health care: Screening for aspartylglucosaminuria mutations in maternity health offices. Clin Chem 1996; 42: 1398-404.
12. Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG. Complete cDNA and derived amino acid sequence of human factor V. Biochemistry 1987; 84: 4846-50.
13. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
14. Livak KJ, Hainer JW. A microtiter plate assay for determining apolipoprotein E genotype and discovery of a rare allele. Hum Mut 1994; 3: 379-85.